Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT).

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 8921782)

Published in Circulation on November 15, 1996

Authors

J Stamler1, A Caggiula, G A Grandits, M Kjelsberg, J A Cutler

Author Affiliations

1: Department of Preventive Medicine, Northwestern University Medical School, Chicago, III, USA.

Associated clinical trials:

Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT) | NCT00000487

A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss (RENEWAL) | NCT03515889

Articles citing this

Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids (2010) 1.75

Relationship of dietary cholesterol to blood pressure: the INTERMAP study. J Hypertens (2011) 1.63

Dietary starch intake of individuals and their blood pressure: the International Study of Macronutrients and Micronutrients and Blood Pressure. J Hypertens (2009) 1.61

Dietary protein and blood pressure: a systematic review. PLoS One (2010) 1.19

High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney. Hypertension (2010) 1.08

Dietary patterns associated with hypertension among Korean males. Nutr Res Pract (2009) 0.95

The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatology (Oxford) (2010) 0.93

Maternal diet during gestation and lactation modifies the severity of salt-induced hypertension and renal injury in Dahl salt-sensitive rats. Hypertension (2014) 0.93

Dietary approaches to prevent hypertension. Curr Hypertens Rep (2013) 0.92

Relationship of dietary monounsaturated fatty acids to blood pressure: the International Study of Macro/Micronutrients and Blood Pressure. J Hypertens (2013) 0.86

Socio-economic & demographic determinants of hypertension & knowledge, practices & risk behaviour of tribals in India. Indian J Med Res (2015) 0.84

Antihypertensive effects of dietary protein and its mechanism. Int J Angiol (2010) 0.84

The antihypertensive effect of arginine. Int J Angiol (2008) 0.81

Eating a healthy lunch improves serum alanine aminotransferase activity. Lipids Health Dis (2013) 0.80

The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study. Semin Arthritis Rheum (2011) 0.80

The antihypertensive effect of cysteine. Int J Angiol (2009) 0.77

Dietary protein intake and coronary heart disease in a large community based cohort: results from the Atherosclerosis Risk in Communities (ARIC) study [corrected]. PLoS One (2014) 0.77

Winter Hypertension: Potential mechanisms. Int J Health Sci (Qassim) (2013) 0.76

The Comparison of Dietary Behaviors among Rural Controlled and Uncontrolled Hypertensive Patients. Adv Prev Med (2016) 0.75

Association between Macronutrients Intake, Visceral Obesity and Blood Pressure in a Sample of Obese Egyptian Women. Open Access Maced J Med Sci (2015) 0.75

Articles by these authors

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA (1998) 7.47

Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension (1995) 6.48

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA (1993) 6.27

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66

Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol (1995) 4.62

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA (1996) 4.54

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int (1997) 4.22

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA (1992) 3.86

Trial of calcium to prevent preeclampsia. N Engl J Med (1997) 3.69

Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27

Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med (1992) 2.96

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77

Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med (1996) 2.62

Change in physician perspective on cholesterol and heart disease. Results from two national surveys. JAMA (1987) 2.17

Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension (1991) 2.04

Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04

Change in public perspective on cholesterol and heart disease. Results from two national surveys. JAMA (1987) 1.98

Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA (1987) 1.86

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension (1997) 1.69

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57

A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clin Cardiol (1999) 1.52

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension (1998) 1.51

Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med (1998) 1.49

Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst (1995) 1.46

Characteristics of smokers and nonsmokers in Tecumseh, Michigan. II. The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and nonsmokers. Am J Epidemiol (1967) 1.43

Characterization of a causative mutation of hemophilia A identified in the promoter region of the factor VIII gene (F8). J Thromb Haemost (2007) 1.38

Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev (1994) 1.34

Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 1.34

Components of hostility as predictors of sudden death and myocardial infarction in the Multiple Risk Factor Intervention Trial. Psychosom Med (1989) 1.33

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA (1996) 1.33

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation (1995) 1.25

Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation (1993) 1.23

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol (1993) 1.22

Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. Hypertension (1993) 1.22

Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med (1997) 1.20

Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev (1996) 1.18

Recruitment of participants for the multiple risk factor intervention trial (MRFIT). Control Clin Trials (1987) 1.18

Calcium-channel blockers for hypertension--uncertainty continues. N Engl J Med (1998) 1.17

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke (1989) 1.17

Statistical analysis of proliferative index data in clinical trials. Stat Med (1994) 1.15

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol (1997) 1.13

The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol (1991) 1.12

Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.11

Dietary protein and blood pressure. JAMA (1996) 1.10

Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens (2005) 1.08

Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. Am J Clin Nutr (1997) 1.04

Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation (2001) 1.03

Obesity, obesity-related behaviors and coronary heart disease risk factors in black and white premenopausal women. Int J Obes (1989) 1.03

Characteristics of smokers and nonsmokers in Tecumseh, Michigan. I. The distribution of smoking habits in persons and families and their relationship to social characteristics. Am J Epidemiol (1967) 1.02

The use of subjective rankings in clinical trials with an application to cardiovascular disease. Stat Med (1992) 1.01

Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 1.01

Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake. Cancer Epidemiol Biomarkers Prev (1999) 1.01

Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA (1999) 1.00

Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am J Med (1984) 0.99

Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group. Control Clin Trials (1989) 0.99

Trials of hypertension prevention. Phase I design. Ann Epidemiol (1991) 0.99

Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav (1996) 0.98

Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I. Am J Epidemiol (1998) 0.97

Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med (1999) 0.96

Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol (1986) 0.96

Prevention and Treatment of Hypertension Study (PATHS). Rationale and design. Am J Hypertens (1994) 0.96

Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J Hypertens Suppl (1986) 0.94

Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial. Ann Epidemiol (1997) 0.93

Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med (1993) 0.93

Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol (1994) 0.91

The epidemiology of plasma testosterone levels in middle-aged men. Am J Epidemiol (1981) 0.91

Acute reinforcing effects of low-dose nicotine nasal spray in humans. Pharmacol Biochem Behav (1997) 0.91

Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials. Prev Med (1985) 0.90

Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiol Biomarkers Prev (1997) 0.90

The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90

Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial. Arch Fam Med (2000) 0.88

Dose-response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study. J Hum Hypertens (2005) 0.88

Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group. Prev Med (1991) 0.88

Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav (1993) 0.88

Adherence to dietary recommendations in the special intervention group in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.87

Upper gastrointestinal bleeding. Nature and magnitude of the problem in the U.S. Dig Dis Sci (1981) 0.87

Influences of the normal menstrual cycle on physiologic functioning during behavioral stress. Psychophysiology (1990) 0.87

Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol (1981) 0.87

Call to develop a standard acquisition charge model for kidney paired donation. Am J Transplant (2012) 0.86

Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. Hypertension (1992) 0.86

Urinary sodium and potassium profile of blacks and whites in relation to education in two different geographic urban areas. TOMHS Research Group. Treatment of Mild Hypertension Study. Am J Hypertens (1999) 0.86

Primary prevention of heart attacks: the multiple risk factor intervention trial. Am J Epidemiol (1980) 0.85

Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men. Am J Cardiol (1984) 0.85

Acute tolerance to nicotine in smokers: lack of dissipation within 2 hours. Psychopharmacology (Berl) (1995) 0.84

Plasma carotenoids as biomarkers of vegetable intake: the University of Minnesota Cancer Prevention Research Unit Feeding Studies. Cancer Epidemiol Biomarkers Prev (1995) 0.84

Effective dietary intervention in hypertensives: sodium restriction and weight reduction. J Am Diet Assoc (1985) 0.84

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. Clin Exp Hypertens A (1989) 0.83

Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.83

Higher education and income are related to a better Na:K ratio in blacks: baseline results of the Treatment of Mild Hypertension Study (TOMHS) data. Am J Hypertens (1997) 0.82

Nutritional adequacy of diets reported at baseline and during trial years 1-6 by the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.80

Diagnostic and therapeutic difficulties in type 2A von Willebrand disease: resolution. Clin Appl Thromb Hemost (2006) 0.80

Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.79

An unexpected result for sodium--causal or casual? Hypertension (1995) 0.79

Planning for emergency medical services in Boston. Public Health Rep (1975) 0.79

Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension (1989) 0.79